-
-
Fapon Biotech Joins Stanford University Healthcare Innovation Lab Affiliates Program
Fapon Biotech, a global leading IVD enterprise, has signed an agreement with Stanford University to become an industry member of the Stanford University Healthcare Innovation Lab (HIL) Affiliates Program. -
Thyroid Function Biomarkers and Their Raw Testing Materials
Since the first International Thyroid Awareness Week in 2009, the public has become increasingly cognizant of the occurrence of thyroid diseases and conversations about the thyroid have reached new heights. Common thyroid diseases include hypothyroidism, hyperthyroidism, thyroid nodules, thyroiditis and thyroid cancer. The main factors behind thyroid diseases are iodine-derived, autoimmune, familial, medical and others, such as infections and dysplasia. -
Fapon Biotech Announces Chemiluminescence One-Stop Solution Strategy in India at Medical Fair India 2023
Fapon Biotech, a global leading IVD enterprise, has announced its innovative chemiluminescence one-stop solution strategy at the 28th edition of Medical Fair India. Fapon chemiluminescence one-stop solution is designed to provide a complete range of chemiluminescence products and services, consisting of different levels of fully automatic chemiluminescence analyzers with open system platforms, reagent development support, as well as high quality core raw material in bulk production. Fapon Biotech aims to help local IVD partners quickly extend their product portfolio and streamline their production processes, as well as accelerate their business in the chemiluminescence immunoassay industry. -
The Urgent Need to Address the Threat of High Prevalence (≥5%) of Malaria Pfhrp2/3 Gene Deletions
HRP2 gene deletions have accounted for more than 5% in some countries and regions. Fapon Biotech has been paying close attention to the worldwide malaria situation and actively responding to the call of WHO. In regards to the above pain points, Fapon Biotech is committed to developing highly sensitive raw materials for LDH tests, and continuously upgrading HRP2 pairs and maintaining world-leading product pairs, and will constantly upgrade and optimize the products to contribute to the eradication of malaria. -
‘Tripledemic:’ FLU, COVID-19 and RSV.
Fapon Biotech has spared no effort in the research and development of raw materials for respiratory diseases, especially for SARS-CoV-2, influenza and RSV. We do provide various raw materials choices for SARS-CoV-2 & FLU A & FLU B combo in rapid test as well. -
Fapon Biotech in Strategic Partnership with Roche Diagnostics
Fapon Biotech Inc. (Fapon Biotech) officially went into strategic partnership with Roche Diagnostics China (Roche Diagnostics) at the 5th China International Import Expo (CIIE) on 5 November 2022.
- Home
- About Fapon Biotech
-
Raw Materials
Application
Disease
New/Featured Products
Technical Support
- Reagent Services
- IVD Ecosystem
- News
- Careers
- Contact us
